From 2023 to 2028, the import quantities of Theophylline and Aminophylline (Theophylline-Ethylenediamine) into China demonstrate a gradual decline. The imports, starting from 519.73 kilograms in 2024, are projected to decrease to 513.03 kilograms by 2028. Comparing 2023 with 2024, we understand there might have been a starting point but the nuances in year-on-year fluctuations will generally show a minor decline in percentage, showing minimal reduction each year.
Future trends to watch for include potential shifts in China's domestic production capabilities, changes in global trade policies, and evolving demand within pharmaceuticals. Additionally, any significant advancements or substitutes for Theophylline and Aminophylline in medical treatments could alter import needs.
